Preclinical efficacy of rVIII-singlechain (CSL627), a novel recombinant FVIII

被引：0
|
作者：
Zollner, S. [1 ]
Raquet, E. [1 ]
Feussner, A. [1 ]
Mueller-Cohrs, J. [1 ]
Metzner, H. [1 ]
Weimer, T. [1 ]
Pragst, I. [1 ]
Dickneite, G. [1 ]
Schulte, S. [2 ]
机构：
[1] CSL Behring GmbH, Preclin Res & Dev, Marburg, Germany
[2] CSL Behring GmbH, Res & Dev, Marburg, Germany
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：40 / 40
页数：1
相关论文
共 47 条
  • [1] Characterization of recombinant single chain FVIII, rVIII-singlechain (CSL627)
    Schmidbauer, S.
    Witzel, R.
    Kreuter, J.
    Schwingal, S.
    Robbel, L.
    Sebastian, P.
    Weimer, T.
    Metzner, H.
    Schulte, S.
    [J]. HAEMOPHILIA, 2012, 18 : 37 - 37
  • [2] Preclinical pharmacokinetic characteristics of rVIII-singlechain (CSL627), a novel recombinant single-chain FVIII
    Zollner, S.
    Raquet, E.
    Feussner, A.
    Maller-Cohrs, J.
    Metzner, H.
    Weimer, T.
    Pragst, I. .
    Dickneite, G.
    Schulte, S.
    [J]. HAEMOPHILIA, 2012, 18 : 40 - 40
  • [3] Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII
    Zollner, Sabine B.
    Raquet, Elmar
    Mueller-Cohrs, Jochen
    Metzner, Hubert J.
    Weimer, Thomas
    Pragst, Ingo
    Dickneite, Gerhard
    Schulte, Stefan
    [J]. THROMBOSIS RESEARCH, 2013, 132 (02) : 280 - 287
  • [4] Preclinical characteristics of rVIII-SingleChain, a novel recombinant single-chain FVIII
    Zollner, S.
    Raquet, E.
    Mueller-Cohrs, J.
    Metzner, H.
    Weimer, T.
    Pragst, I.
    Dickneite, G.
    Schulte, S.
    [J]. HAEMOPHILIA, 2012, 18 : 38 - 39
  • [5] Preclinical Characteristics of rVIII-SingleChain, A Novel Recombinant Single-Chain FVIII
    Zollner, Sabine
    Raquet, Elmar
    Mueller-Cohrs, Jochen
    Metzner, Hubert
    Weimer, Thomas
    Pragst, Ingo
    Schulte, Stefan
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S147 - S148
  • [6] Functional characterization of rVIII-SingleChain and comparison with commercially available recombinant FVIII products
    Horn, C.
    Watzka, B.
    Metzner, H. J.
    Dickneite, G.
    Schulte, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 581 - 581
  • [7] Efficacy and safety of RVIII-singlechain in surgical prophylaxis
    Mancuso, M. E.
    Male, C.
    Karim, F. Abdul
    Khayat, C. Djambas
    Mahlangu, J.
    Baker, R. I.
    Oldenburg, J.
    Ong, J.
    P'ng, S.
    Leissinger, C.
    Brainsky, A.
    Lucas, S.
    Pabinger, I.
    [J]. HAEMOPHILIA, 2018, 24 : 103 - 103
  • [8] Efficacy and safety of RVIII-singlechain in surgical prophylaxis
    Khayat, Djambas C.
    Mahlangu, J.
    Leisinger, C.
    P'ng, S.
    Santagostino, E.
    Fernandez, F. L.
    Kennedy, D. B.
    Veldman, A.
    Regina, C.
    Pabinger, I
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 602 - 602
  • [9] Pre-clinical pharmacokinetic and pharmacodynamic (PK/PD) characteristics of rVIII-SingleChain, a novel recombinant single-chain FVIII
    Zollner, S.
    Raquet, E.
    Feussner, A.
    Mueller-Cohrs, J.
    Metzner, H.
    Weimer, T.
    Pragst, I
    Dickneite, G.
    Schulte, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 975 - 975
  • [10] Interim Analysis of the Extension Study with rVIII-SingleChain in Previously Untreated Patients (PUPs) with Severe Hemophilia A (CSL627-3001)
    Santagostino, Elena
    Fischer, Kathelijn
    Koenigs, Christoph
    Khayat, Claudia Djambas
    Lucas, Samantha
    Salazar, Blanca
    Brainsky, Andres
    Chung, Thomas
    Goldstein, Brahm
    Mahlangu, Johnny
    [J]. BLOOD, 2019, 134
12345